Summary
Control bone marrow was obtained from two hematologically normal children aged I and 13 years with localized solid tumors T o study the action of corticosteroids on erythroid precursors, who had marrow aspirates performed as part of their medical (burst forming unit-erythroid and colony forming unit-erythroid) investigation. This study was approved by the Human Experiin Diamond-Blackfan Syndrome (DBS), marrow from a newly mentation of the Hospital for Sick Children and diagnosed untreated infant was studied in vitro with prednisone informed consent obtained, and dexamethasone. This patient subsequently proved to be steroid Or dexamethasone (lo-' M, the cultures' The data at a Anal volume of I ml per culture plate (10) . Human urinary indicate that corticosteroids augment erythropoiesis at both early erythropoietin (EPO) (National Heart Lung and Blood Institute, (BFU-E) and late (CFU-E) stages in DBS. In Bethesda, MD) of purity 93.5 units/mg protein was added to the contrast, marrow from a second infant with DBS, clinically steroid cultures in the corticosteroid dose response studies and EPO of resistant, failed to respond to steroids in vitro. purity 3,742 units/mg protein was used in the EPO dose response study. In all studies 10" marrow cells from controls and 10" from Speculation the DBS patients were plated per culture. The cultures were It seems reasonable that in some patients with Diamond-Blackincubated at 37°C for 7 or 14 days in air with 5% CO., and high fan syndrome, erytt,roid precursors have a relative insensitivity to humidity. Colonies were counted directly in the culture plates erythropoietin (EPO). Corticosteroids appear able to modify EPO using an inverted An aggregate more lhan 500 receptor sites on the progenitor cell membrane in ,,itro, thus hemoglobinized cells or three or more erythroid subcolonies on increasing E P O sensitivity and partially correcting the erythro-day 14 was considered a "burst" or BFU-E colony (8) . A CFU-E poietic defect.
colony was defined as a cluster of 8 or more hemoglobinized cells on day 7. All studies were performed in duplicate and the results expressed as mean colony number/l0 cells plated.
Diamond and Blackfan described a syndrome of congenital red
Steroid studies. Dexamethasone and prednisone were dissolved cell asplasia (3) (Diamond-Blackfan Anemia or Syndrome, DBS), in 100% ethanol, serially diluted with alpha medium (University which responds to corticosteroid therapy in the majority of patients of Toronto, Toronto. Ontario, Canada) and added to the cultures (4) . The bone marrow is initially devoid of recognizable erythroid for the duration of the incubation. To determine optimum drug cells; however, with treatment, it develops active erythropoiesis doses, dose response studies were done with concentrations of leading to reticulocytosis and a rise in hemoglobin. The mecha-dexamethasone ranging from 10-"-10-~' M and concentrations of nism and site of action of corticosteroids is unknown.
prednisone from IO-"-I-' M. Controls without added drug or In most patients with DBS, marrow erythroid precursor cells, with ethanol only in concentrations from 1%-0.0001% were also colony forming unit-erythroid (CFU-E) and burst forming unit-cultured. erythroid (BFU-E), are present which are capable of replication and differentiation in tissue culture to colonies containing mor-RESULTS phologically recognizable erythroid cells (5) . Although the concentration of these progenitors has appeared to be lower than In dose response studies using cultures of two control marrows normal when studied by conventional marrow culture methods there was a increase in CFU-E and BFU-E using (5, 11) cell fractionation techniques have provided information prednisone lo-" M and dexamethasone lo-" M ( Fig. 1 ). At these that some patients with DBS have normal CFU-E and BFU-E drug concentrations the ethanol solvent had no effect on colony numbers (I, 6) .
number. No colonies were seen in cultures without added EPO. TO study the action of corticosteroids on erythroid precursors in The culture results using marrow from patient 1 with three EPO the disorder, marrows from two newly-diagnosed, untreated in-concentrations at optimal doses of prednisone or dexamethasone fants with DBS were studied in "itro with prednisone and dexa-are shown in Fig. 2 . There was a linear increase in colony numbers methasone, ~h~ data show that these agents enhanced erythroid in cultures without corticosteroids. With added prednisone or progenitor growth at both early and late stages of cellular differ-dexamethasone. there was enhancement of colony entiation in the steroid-responsive patient.
numbers at all EPO concentrations (P < 0.001). However, colony numbers reached only approximately 50% of control colony num-
bers at 1 units/ml of EPO. There was no difference in the erythropoietic stimulatory effect between the two drugs. In each Subjects. The infants fit the classical description of DBS (4) CFU-E and 1 BFU-E/I@ cells grew and there was no increase with either steroid.
D I S C U S S I O N
Our data indicate that two corticosteroids, prednisone and dexamethasone, enhanced the replication and differentiation of erythroid progenitors from marrow of patient 1 in vitro at both early (BFU-E) and late (CFU-E) stages of development. Golde et al. (7) documented that dexamethasone potentiated CFU-E growth when added to cultures of fetal mouse liver, adult murine -marrow, and human marrow. The mechanism of the stirnulatory action was uncertain but it was only seen in cultures containing EPO. Both EPO and corticosteroids are thought to act at cell receptor sites (2, 12, 13) . Since the dexamethasone-induced erythropoietic stimulation can be abolished by progesterone (7) , an agent that blocks corticosteroid activity by interfering with its binding to cell receptor sites (12, 13) , it seems reasonable that EPO and corticosteroids could interact in some manner at cell receptor sites to produce their effect.
One can speculate that such an interaction between EPO and corticosteroids took place on the erythroid precursors of the steroid responsive patient (Patient I ) leading to a partial correction of the defect in vitro. In contrast, steroids in vitro completely failed to stimulate colony growth from the marrow of the clinically steroid resistant patient (Patient 2). The exact defect in DBS is not known but it appears to be a heterogeneous disorder both in vitro (6, 9) and clinically.
